Universal Health Services, Inc. (0LJL.L)
USD 181.27
(-0.29%)
USD 181.27
(-0.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.17 Billion USD | -90.14% |
| 2022 | 11.92 Billion USD | 6.33% |
| 2021 | 11.21 Billion USD | 9.19% |
| 2020 | 10.27 Billion USD | 1.42% |
| 2019 | 10.12 Billion USD | 5.45% |
| 2018 | 9.6 Billion USD | 3.21% |
| 2017 | 9.3 Billion USD | 6.52% |
| 2016 | 8.73 Billion USD | 8.25% |
| 2015 | 8.06 Billion USD | 12.55% |
| 2014 | 7.16 Billion USD | 10.94% |
| 2013 | 6.46 Billion USD | 4.88% |
| 2012 | 6.16 Billion USD | 87.66% |
| 2011 | 3.28 Billion USD | 36.13% |
| 2010 | 2.41 Billion USD | 4.93% |
| 2009 | 2.29 Billion USD | -46.89% |
| 2008 | 4.32 Billion USD | 112.62% |
| 2007 | 2.03 Billion USD | 10.81% |
| 2006 | 1.83 Billion USD | 0.96% |
| 2005 | 1.81 Billion USD | 1.97% |
| 2004 | 1.78 Billion USD | -22.39% |
| 2003 | 2.29 Billion USD | 12.35% |
| 2002 | 2.04 Billion USD | 13.41% |
| 2001 | 1.8 Billion USD | 26.56% |
| 2000 | 1.42 Billion USD | 17.48% |
| 1999 | 1.21 Billion USD | 8.18% |
| 1998 | 1.12 Billion USD | 29.3% |
| 1997 | 867.6 Million USD | 18.51% |
| 1996 | 732.1 Million USD | 28.42% |
| 1995 | 570.1 Million USD | 17.76% |
| 1994 | 484.1 Million USD | 311.65% |
| 1993 | 117.6 Million USD | -13.08% |
| 1992 | 135.3 Million USD | 25.86% |
| 1991 | 107.5 Million USD | 20.65% |
| 1990 | 89.1 Million USD | 13.21% |
| 1989 | 78.7 Million USD | -4.49% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 436.39 Million USD | 12.25% |
| 2024 Q3 | 2.83 Billion USD | 718.7% |
| 2024 Q1 | 388.76 Million USD | 17.38% |
| 2023 Q3 | 3.18 Billion USD | 0.51% |
| 2023 Q1 | 3.08 Billion USD | 0.73% |
| 2023 Q2 | 3.16 Billion USD | 2.6% |
| 2023 FY | 1.17 Billion USD | -90.14% |
| 2023 Q4 | 331.19 Million USD | -89.6% |
| 2022 Q2 | 2.96 Billion USD | 1.59% |
| 2022 Q4 | 3.06 Billion USD | 3.21% |
| 2022 FY | 11.92 Billion USD | 6.33% |
| 2022 Q1 | 2.92 Billion USD | 0.72% |
| 2022 Q3 | 2.96 Billion USD | 0.04% |
| 2021 Q2 | 2.85 Billion USD | 7.28% |
| 2021 Q1 | 2.66 Billion USD | -2.55% |
| 2021 Q3 | 2.78 Billion USD | -2.51% |
| 2021 FY | 11.21 Billion USD | 9.19% |
| 2021 Q4 | 2.9 Billion USD | 4.05% |
| 2020 Q1 | 2.51 Billion USD | -2.34% |
| 2020 Q4 | 2.73 Billion USD | 6.15% |
| 2020 Q3 | 2.57 Billion USD | 5.35% |
| 2020 Q2 | 2.44 Billion USD | -2.61% |
| 2020 FY | 10.27 Billion USD | 1.42% |
| 2019 Q2 | 2.54 Billion USD | 2.1% |
| 2019 Q1 | 2.49 Billion USD | 1.76% |
| 2019 FY | 10.12 Billion USD | 5.45% |
| 2019 Q3 | 2.5 Billion USD | -1.6% |
| 2019 Q4 | 2.57 Billion USD | 2.54% |
| 2018 Q4 | 2.45 Billion USD | 3.81% |
| 2018 FY | 9.6 Billion USD | 3.21% |
| 2018 Q2 | 2.39 Billion USD | -0.12% |
| 2018 Q1 | 2.39 Billion USD | 1.55% |
| 2018 Q3 | 2.36 Billion USD | -1.17% |
| 2017 FY | 9.3 Billion USD | 6.52% |
| 2017 Q3 | 2.27 Billion USD | -2.74% |
| 2017 Q4 | 2.35 Billion USD | 3.7% |
| 2017 Q2 | 2.33 Billion USD | 0.11% |
| 2017 Q1 | 2.33 Billion USD | 5.58% |
| 2016 Q2 | 2.17 Billion USD | -0.83% |
| 2016 Q4 | 2.21 Billion USD | 2.78% |
| 2016 FY | 8.73 Billion USD | 8.25% |
| 2016 Q1 | 2.19 Billion USD | 6.37% |
| 2016 Q3 | 2.15 Billion USD | -1.12% |
| 2015 Q2 | 2.03 Billion USD | 2.4% |
| 2015 FY | 8.06 Billion USD | 12.55% |
| 2015 Q3 | 1.98 Billion USD | -2.4% |
| 2015 Q4 | 2.06 Billion USD | 3.92% |
| 2015 Q1 | 1.98 Billion USD | 6.0% |
| 2014 Q3 | 1.79 Billion USD | -0.06% |
| 2014 Q2 | 1.79 Billion USD | 5.38% |
| 2014 Q1 | 1.7 Billion USD | 6.94% |
| 2014 FY | 7.16 Billion USD | 10.94% |
| 2014 Q4 | 1.87 Billion USD | 4.41% |
| 2013 Q2 | 1.63 Billion USD | 0.35% |
| 2013 Q1 | 1.62 Billion USD | 4.28% |
| 2013 FY | 6.46 Billion USD | 4.88% |
| 2013 Q4 | 1.59 Billion USD | -0.97% |
| 2013 Q3 | 1.6 Billion USD | -1.42% |
| 2012 Q3 | 1.48 Billion USD | -2.81% |
| 2012 Q1 | 1.61 Billion USD | 106.79% |
| 2012 Q4 | 1.56 Billion USD | 4.81% |
| 2012 FY | 6.16 Billion USD | 87.66% |
| 2012 Q2 | 1.53 Billion USD | -5.2% |
| 2011 Q2 | 844.56 Million USD | -1.51% |
| 2011 Q1 | 857.49 Million USD | 29.48% |
| 2011 Q3 | 800.02 Million USD | -5.27% |
| 2011 Q4 | 781.33 Million USD | -2.34% |
| 2011 FY | 3.28 Billion USD | 36.13% |
| 2010 Q3 | 570.49 Million USD | -4.09% |
| 2010 FY | 2.41 Billion USD | 4.93% |
| 2010 Q4 | 662.24 Million USD | 16.08% |
| 2010 Q1 | 584.41 Million USD | 6.05% |
| 2010 Q2 | 594.83 Million USD | 1.78% |
| 2009 Q2 | 585.27 Million USD | -1.99% |
| 2009 FY | 2.29 Billion USD | -46.89% |
| 2009 Q4 | 551.06 Million USD | -2.5% |
| 2009 Q3 | 565.21 Million USD | -3.43% |
| 2009 Q1 | 597.15 Million USD | -44.04% |
| 2008 Q2 | 565.33 Million USD | -0.02% |
| 2008 Q1 | 565.43 Million USD | 11.7% |
| 2008 FY | 4.32 Billion USD | 112.62% |
| 2008 Q3 | 1.07 Billion USD | 89.93% |
| 2008 Q4 | 1.06 Billion USD | -0.61% |
| 2007 FY | 2.03 Billion USD | 10.81% |
| 2007 Q4 | 506.21 Million USD | -0.15% |
| 2007 Q1 | 511.25 Million USD | 14.13% |
| 2007 Q2 | 511.15 Million USD | -0.02% |
| 2007 Q3 | 506.95 Million USD | -0.82% |
| 2006 FY | 1.83 Billion USD | 0.96% |
| 2006 Q3 | 437.41 Million USD | -10.38% |
| 2006 Q1 | 463.54 Million USD | 7.52% |
| 2006 Q2 | 488.1 Million USD | 5.3% |
| 2006 Q4 | 447.95 Million USD | 2.41% |
| 2005 FY | 1.81 Billion USD | 1.97% |
| 2005 Q4 | 431.14 Million USD | -5.8% |
| 2005 Q3 | 457.7 Million USD | 0.18% |
| 2005 Q2 | 456.86 Million USD | -9.25% |
| 2005 Q1 | 503.42 Million USD | 26.07% |
| 2004 FY | 1.78 Billion USD | -22.39% |
| 2004 Q2 | 464.61 Million USD | -1.02% |
| 2004 Q3 | 459.05 Million USD | -1.2% |
| 2004 Q4 | 399.32 Million USD | -13.01% |
| 2004 Q1 | 469.38 Million USD | -21.27% |
| 2003 Q2 | 569.78 Million USD | -0.59% |
| 2003 Q3 | 563.01 Million USD | -1.19% |
| 2003 FY | 2.29 Billion USD | 12.35% |
| 2003 Q4 | 596.17 Million USD | 5.89% |
| 2003 Q1 | 573.16 Million USD | -2.45% |
| 2002 Q4 | 587.56 Million USD | 19.97% |
| 2002 FY | 2.04 Billion USD | 13.41% |
| 2002 Q1 | 508.96 Million USD | 12.25% |
| 2002 Q2 | 503.79 Million USD | -1.02% |
| 2002 Q3 | 489.77 Million USD | -2.78% |
| 2001 Q3 | 458.55 Million USD | 0.62% |
| 2001 Q2 | 455.74 Million USD | 4.37% |
| 2001 Q4 | 453.4 Million USD | -1.12% |
| 2001 FY | 1.8 Billion USD | 26.56% |
| 2001 Q1 | 436.67 Million USD | 12.24% |
| 2000 Q4 | 389.03 Million USD | 9.62% |
| 2000 Q1 | 350.15 Million USD | 16.64% |
| 2000 Q2 | 331.61 Million USD | -5.29% |
| 2000 Q3 | 354.88 Million USD | 7.02% |
| 2000 FY | 1.42 Billion USD | 17.48% |
| 1999 Q2 | 308.4 Million USD | -2.71% |
| 1999 Q1 | 317 Million USD | 7.06% |
| 1999 FY | 1.21 Billion USD | 8.18% |
| 1999 Q4 | 300.2 Million USD | 4.2% |
| 1999 Q3 | 288.1 Million USD | -6.58% |
| 1998 Q1 | 282.1 Million USD | 20.35% |
| 1998 FY | 1.12 Billion USD | 29.3% |
| 1998 Q3 | 264 Million USD | -5.55% |
| 1998 Q4 | 296.1 Million USD | 12.16% |
| 1998 Q2 | 279.5 Million USD | -0.92% |
| 1997 Q4 | 234.4 Million USD | 8.97% |
| 1997 FY | 867.6 Million USD | 18.51% |
| 1997 Q1 | 210.5 Million USD | 5.2% |
| 1997 Q2 | 207.5 Million USD | -1.43% |
| 1997 Q3 | 215.1 Million USD | 3.66% |
| 1996 Q2 | 177.4 Million USD | 4.78% |
| 1996 Q1 | 169.3 Million USD | 4.7% |
| 1996 FY | 732.1 Million USD | 28.42% |
| 1996 Q4 | 200.1 Million USD | 7.93% |
| 1996 Q3 | 185.4 Million USD | 4.51% |
| 1995 Q2 | 130.1 Million USD | -4.48% |
| 1995 FY | 570.1 Million USD | 17.76% |
| 1995 Q4 | 161.7 Million USD | 13.79% |
| 1995 Q3 | 142.1 Million USD | 9.22% |
| 1995 Q1 | 136.2 Million USD | -64.45% |
| 1994 Q1 | 37 Million USD | 37.04% |
| 1994 Q2 | 33.5 Million USD | -9.46% |
| 1994 Q3 | 30.5 Million USD | -8.96% |
| 1994 Q4 | 383.1 Million USD | 1156.07% |
| 1994 FY | 484.1 Million USD | 311.65% |
| 1993 Q2 | 29.6 Million USD | -10.84% |
| 1993 Q3 | 27.8 Million USD | -6.08% |
| 1993 Q4 | 27 Million USD | -2.88% |
| 1993 FY | 117.6 Million USD | -13.08% |
| 1993 Q1 | 33.2 Million USD | 25.76% |
| 1992 FY | 135.3 Million USD | 25.86% |
| 1992 Q4 | 26.4 Million USD | 3.53% |
| 1992 Q3 | 25.5 Million USD | -14.72% |
| 1992 Q2 | 29.9 Million USD | -43.9% |
| 1992 Q1 | 53.3 Million USD | 169.19% |
| 1991 Q3 | 24.4 Million USD | -17.01% |
| 1991 Q4 | 19.8 Million USD | -18.85% |
| 1991 Q2 | 29.4 Million USD | -13.27% |
| 1991 FY | 107.5 Million USD | 20.65% |
| 1991 Q1 | 33.9 Million USD | 100.59% |
| 1990 FY | 89.1 Million USD | 13.21% |
| 1990 Q2 | 20.7 Million USD | -87.57% |
| 1990 Q4 | 16.9 Million USD | -3.43% |
| 1990 Q1 | 166.5 Million USD | 13.65% |
| 1990 Q3 | 17.5 Million USD | -15.46% |
| 1989 FY | 78.7 Million USD | -4.49% |
| 1989 Q3 | 140.2 Million USD | -4.63% |
| 1989 Q1 | 153.5 Million USD | 12.04% |
| 1989 Q2 | 147 Million USD | -4.23% |
| 1989 Q4 | 146.5 Million USD | 4.49% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -482.607% |
| Accuray Incorporated | 143.12 Million USD | -721.25% |
| Align Technology, Inc. | 2.72 Billion USD | 56.79% |
| Elevance Health Inc. | 47.01 Billion USD | 97.5% |
| AxoGen, Inc. | 127.87 Million USD | -819.171% |
| Boston Scientific Corporation | 9.84 Billion USD | 88.066% |
| CVS Health Corporation | 54.43 Billion USD | 97.841% |
| Cardinal Health, Inc. | 7.41 Billion USD | 84.146% |
| Centene Corporation | 153.99 Billion USD | 99.237% |
| DaVita Inc. | 3.82 Billion USD | 69.234% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 97.866% |
| Hologic, Inc. | 2.23 Billion USD | 47.476% |
| Humana Inc. | 106.44 Billion USD | 98.896% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 46.329% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 65.069% |
| Masimo Corporation | 1 Billion USD | -17.128% |
| McKesson Corporation | 12.58 Billion USD | 90.66% |
| Patterson Companies, Inc. | 1.38 Billion USD | 14.842% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 60.305% |
| ResMed Inc. | 2.6 Billion USD | 54.945% |
| Henry Schein, Inc. | 3.65 Billion USD | 67.807% |
| Teladoc Health, Inc. | 1.84 Billion USD | 36.203% |
| Veeva Systems Inc. | 1.68 Billion USD | 30.302% |
| Baxter International Inc. | 4.97 Billion USD | 76.374% |
| Becton, Dickinson and Company | 8.82 Billion USD | 86.678% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 75.148% |
| Danaher Corporation | 14.12 Billion USD | 91.681% |
| Stryker Corporation | 13.05 Billion USD | 90.999% |
| Medtronic plc | 21.27 Billion USD | 94.475% |